Title: Comparative Study between Tamsulosin and Silodosin as a Medical Expulsive Therapy for Lower Ureteral Stones

Authors: Dr Md. Shahidul Islam, Dr Md. Mostafiger Rahman, Dr Wahida Akhtar Chowdhury, Dr Md. Mahabubul Islam, Dr Mst. Rawshon Ara Begum

 DOI: https://dx.doi.org/10.18535/jmscr/v8i9.07

Abstract

Objectives: To compare the efficacy of tamsulosin and silodosin as medical expulsive therapy (MET) for lower ureteric stones.

Materials and Methods: A prospective randomized study was conducted at outpatient department of Urology, Rangpur Medical College Hospital, Rangpur, Bangladesh during January 2017 and May 2019. A total of 220 patients with single unilateral lower ureteric stones 10 mm or less were included in this study.Cases were selected by inclusion and exclusion criteria and randomly allocated in two groups. Tamsulosin group (110 patients) and silodosin group (110 patients) were given tamsulosin 0.4mg and silodosin 8 mg daily at bed time respectively. The patients were prescribed diclofenac (50 mg) on demand for pain relief and were followed-up on weekly for 4 weeks by X-ray and ultrasonography of kidney, ureter and urinary bladder region. The expulsion rate, expulsion time, and analgesic requirements were also recorded. Data were analyzed and compared by statistical tests.

Results: According to our results, no statistically significant difference was found in terms of age, gender and stone size distribution between two groups. The stone expulsion rate was significantly higher in the silodosin group compared with the tamsulosin group, at 85.46% and 70.91%, respectively (p = 0.009). The stone expulsion time was also significantly lower in silodosin against tamsulosin groups as it was 13.12 ± 5.65 days vs.16.6± 5.2 days  respectively (p = 0.0001). The variation between analgesic doses required by patients in both groups were found statistically not significant (p=0.158).Overall, adverse effects were similar in both groups.

Conclusions: Silodosin is more effective than tamsulosin as medical expulsive therapy for lower ureteric stones.

Keywords: Tamsulosin,Silodosin, Ureter, Stone.

References

  1. Turney BW, Reynard JM, Noble JG, Keoghane SR. Trends in urological stone disease. BJU Int 2012;109:1082–1087.
  2. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. Journal of Nephrology 2000;13Suppl 3: S45–50. [MEDLINE: 11132032]
  3. Pearle MS and LotanY ;Urinary lithiasis: etiology, epidemiology and pathogenesis. In: Campbell-Walsh Urology. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. 10th ed. Philadelphia: Saunders Elsevier, 2012: pp: 1257-1286.
  4. R Ranjan, P Kumari, M Mundu, R Baxla. The role of tamsulosin and deflazacort in the expulsion of up to 6 in mid and lower ureteric calculi . The Internet Journal of Urology. 2013: 11(1).
  5. Michael E.L, Michael N.F., Glenn M.P. Evaluation and medical management of urinary urolithiasis.In: Campbell-Walsh Urology. Wein AJ, Kavoussi LR, Partin AW, Peters CA. , editors. 11th ed. Philadelphia: Elsevier; 2016. pp 1200-1234
  6. Preminger GM, Tiselius H-G, Assimos DG, et al. 2007 Guideline for the management of ureteral calculi. J Urol. 2007;178:2418-2434.
  7. Türk C, Petrík A, Sarica K, et al. EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol. 2016;69:468-474.
  8. Malin JM Jr, Deane RF, Boyarsky S. Characterisation of adrenergic receptors in human ureter.Br J Urol. 1970; 42:171-4.
  9. Küpeli B, Irkilata L, Gürocak S, et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wavelithotripsy? Urology. 2004; 64:1111-5.
  10. Itoh Y, Kojima Y, Yasui T, et al. Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol. 2007; 14:749-53.
  11. Yilmaz E, Batislam E, Basar MM, et al. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol. 2005; 173:2010-2.
  12. De Sio M, Autorino R, Di Lorenzo G, et al. Medical expulsive treatment of distal-ureteral stones using tamsulosin: a single-center experience. J Endourol. 2006; 20:12-6.
  13. Singh A, Alter HJ, Littlepage A. A systematic review of medical therapy to facilitate passage of ureteral calculi. Ann Emerg Med 2007; 50:552-63.
  14. Yuksel M, Yilmaz S, Tokgoz H, et al. Efficacy of silodosin in the treatment of distal ureteral stones 4 to 10 mm in diameter. Int J ClinExp Med. 2015;8(10):19086–19092.
  15. Ahmad H, Azim W, Akmal M, Murtaza B, Mahmood A, Nadim A, et al. Medical expulsive treatment of distal ureteral stone using tamsulosin. J Ayub Med Coll Abbottabad. 2015;27 (1):4850.
  16. Campschroer T, Zhu X, Vernooij RWM, Lock MTWT. Alpha‐blockers as medical expulsive therapy for ureteral stones. Cochrane Database of Systematic Reviews 2018, Issue 4. Art. No.: CD008509. DOI: 10.1002/14651858.CD008509.pub3.
  17. Gharib T, Mohey A, Fathi A, Alhefnawy M, Alazaby H, Eldakhakhny A. Comparative Study between Silodosin and Tamsulosin in Expectant Therapy of Distal Ureteral Stones. UrolInt2018;101:161–166 https://doi.org/10.1159/000490623.
  18. Elgalaly H, Sakr A, Fawzi A, et al. Silodosin vs tamsulosin in the management of distal ureteric stones: A prospective randomised study. Arab J Urol. 2016;14(1):12–17. doi:10.1016/j.aju.2015.11.004
  19. Tsuzaka Y, Matsushima H, Kaneko T, et al: Naftopidilvs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients. Int J Urol 2011; 18: 792–795.
  20. Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol2005;174:167–72
  21. Bensalah K, Pearle M, Lotan Y: Cost effectiveness of medical expulsive therapy using alpha blockers for the treatment distal ureteral stones. EurUrol 2008; 53: 411–418.
  22. Wolf JS Jr: Treatment selection and outcomes: ureteral calculi. UrolClin N Am 2007; 34: 421–430
  23. Tiselius HG, Ackermann D, Alken P, et al. Guidelines on urolithiasis. European Association of Urology [website]. https://uroweb.org/wp-content/uploads/EAU-Guidelines-Urolithiasis-2008.pdf
  24. Cervenakov I, Fillo J, Mardaik J, Kopency M, Smilrala J, Lepies. Speedy elimination of urolithiasis in lower part of ureters with alpha1 blockers tamsulosin. Int J Urol Nephrol. 2002; 34:25-9.
  25. Pricop C, Novac C, Negru D, Iiie C, Pricop A, Tanase A. Can selective alpha blockers help the spontaneous passage of the stones located in the uretero bladder junction? Rev Med ChirSoc Med Nat. 2004; 108:128–33.
  26. Gupta S, Lodh B, Singh AK, Somarendra K, Meitei KS, Singh SR. Comparing the efficacy of tamsulosin and silodosin in the medical expulsion therapy for ureteral calculi. J ClinDiagn Res 2013;7:1672–4.
  27. Kumar S, Jayant K, Agrawal MM, Singh SK, Agrwal S, Parmar KM. Role of tamsulosin, tadalafil, and silodosin as the medical expulsive therapy in lower ureteric stone: a randomized trial (a pilot study). Urology 2015;85:59–63
  28. Imperatore V, Fusco F, Creta M, Di Meo S, Buonopane R, Longo N, et al. Medical expulsive therapy for distal ureteric stones: tamsulosin versus silodosin. Arch ItalUrolAndrol2014;86:103–7.
  29. Dell’Atti L: Silodosin versus tamsulosin as medical expulsive therapy for distal ureteral stones: a prospective randomized study. Urologia. 2014, 82:54–7. 10.5301/uro.5000083
  30. Gharib T, Mohey A, Fathi A, Alhefnawy M, Alazaby H, Eldakhakhny A: Comparative Study between Silodosin and Tamsulosin in Expectant Therapy of Distal Ureteral Stones. UrolInt2018;101:161-166. doi: 10.1159/000490623.

Corresponding Author

Dr Md. Shahidul Islam

Associate Professor, Department of Urology, Rangpur Medical College, Rangpur, Bangladesh